EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Special Population

Winston Dunn, Aleksander Krag, Patrick Kamath, Ashwani K Singal

Clinics in Liver Disease · 2026-05 · 30 (2) · 449-467

DOI: 10.1016/j.cld.2026.01.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-05. Verfasst von Winston Dunn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Gastroenterology Hepatology Division, Kansas University Medical Center, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Metabolic Syndrome, Alcohol Drinking. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nomenclature of steatotic liver disease advanced our understanding of the interplay between alcohol and cardiometabolic risk factors. The new nomenclature introduced a new entity of metabolic dysfunction and alcohol associated liver disease or Met-ALD. This brought in challenges like granular self-reported quantification on self-reported alcohol use and changing disease states due to dynamic alcohol use, with risk of misclassification of alcohol use. Every challenge brings in an opportunity and so is with this new entity bringing in new opportunities in clinical care and in research. These opportunities include but not limited to prevalence and healthcare burden, risk stratification using non-invasive tests, prognosis and natural history, management with pharmacological targets, and enrolment with end points in clinical trials. Given a worldwide increasing prevalence of metabolic syndrome and of alcohol use, this article delves into a global perspective on the challenges and opportunities in the understanding of Met-ALD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Diseases, AlcoholicMetabolic SyndromeAlcohol DrinkingHumansGlobal HealthRisk FactorsFatty Liver, Alcoholic

Stichwörter der Autor:innen

AlcoholCirrhosisMetALDMortality

Autor:innen und Institutionen

  • Department of Medicine, Gastroenterology Hepatology Division, Kansas University Medical Center, Kansas City, KS, USA.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Global NASH/MASH Council, Washington, DC, USA.
  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Global NASH/MASH Council, Washington, DC, USA; University of Louisville School of Medicine, R-505, 505 South Hancock Street, Louisville, KY 40202, USA; Rob Rexley VA Medical Center, Louisville, KY, USA; University of Lo…

Förderung

  • NIGMS NIH HHS
  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institutes of Health

Zitieren

APA

Dunn, W., Krag, A., Kamath, P., & Singal, A. K. (2026). Special Population. Clinics in Liver Disease, 30(2), 449-467. https://doi.org/10.1016/j.cld.2026.01.007

Vancouver

Dunn W, Krag A, Kamath P, Singal AK. Special Population. Clinics in Liver Disease. 2026;30(2):449-467. doi:10.1016/j.cld.2026.01.007

BibTeX
@article{Dunn2026,
  author = {Dunn, Winston and Krag, Aleksander and Kamath, Patrick and Singal, Ashwani K},
  title = {Special Population},
  journal = {Clinics in Liver Disease},
  year = {2026},
  volume = {30},
  number = {2},
  pages = {449--467},
  doi = {10.1016/j.cld.2026.01.007}
}
Kostenlos starten →